Uterine Leiomyoma Research Center Program
Uterine Leiomyoma Research Center Program
批准号:
8308004
负责人:
Serdar E. Bulun
金额:
$112.72万
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-08-15 至 2014-06-30
关键词:
AffectAnemiaAnti-ProgestinApoptosisBenignCell Culture TechniquesCell SurvivalCellsCollagen Type IDevelopmentDiseaseEnvironmentExhibitsExtracellular MatrixFibroid TumorFutureGenesGoalsGrowthGrowth and Development functionGynecologicHormonalHysterectomyInstructionLeadLeiomyomaMolecularPI3K/AKTPathway interactionsPharmaceutical PreparationsPharmacologic SubstancePregnancy lossProgesteroneProgesterone ReceptorsProgestinsProto-Oncogene Proteins c-aktRU-486RecurrenceResearchRoleSignal PathwaySignal TransductionSmooth Muscle MyocytesTestingTissue ProcurementsTransforming Growth Factor betaType I Epithelial Receptor CellUterine FibroidsUterine hemorrhageWomancell growthdesigninhibitor/antagonistmultidisciplinarynovel therapeuticsprogramsresponsetranscription factortranslational studytumortumor growth
中文摘要
子宫平滑肌瘤(肌瘤)是美国最常见的良性妇科疾病。的
平滑肌瘤发生和生长的细胞和分子机制尚不清楚,
明白我们的多学科团队已经设计了3个整合良好的项目,重点是互动
子宫肌瘤中涉及转录因子的生物学关键激素途径
孕酮受体(PR)和FOXO、信号传导途径PI 3 K/AKT和促纤维化因子TGF-β。
项目I(布伦)将继续研究,以了解抗孕激素(如RU 486)
减小肿瘤大小。我们假设孕酮调节了一些关键基因,这有利于
增加平滑肌瘤平滑肌细胞的增殖和减少凋亡,而抗孕激素
通过增强凋亡和减少增殖来逆转这种效应。项目二(Kim/Chakravarti)将
确定PI 3 K/AKT/F0 X 0信号通路调节平滑肌瘤细胞生长和存活的作用,
对孕酮的反应我们推测孕酮诱导平滑肌瘤细胞增殖
通过激活PI 3 K/AKT/F0 X 0信号通路,AKT通路的抑制剂应
克服孕酮的增殖作用并促进凋亡。项目三(诺瓦克)将确定
抗纤维化药物如何调节平滑肌瘤生长的机制。我们假设,
平滑肌瘤平滑肌细胞的增殖是由于细胞外基质的主要转移
由这些细胞增加的新的单体I型胶原蛋白的合成引起的环境。我们将
确定抗纤维化药物是否可能是一种有效的治疗平滑肌瘤的新方法。这些项目
由一个行政核心(布伦)和组织采购和细胞培养核心(栗田)支持。
总的来说,作为我们长期目标的一部分,所有项目都研究了调节细胞凋亡的局部激素信号传导
和增殖作为生物学终点,并测试现有的和即将推出的药物化合物,
子宫平滑肌瘤中的这些通路。
英文摘要
Uterine leiomyomata (fibroids) represent the most prevalent benign gynecologic disorder in the US. The
cellular and molecular mechanisms regulating the development and growth of leiomyoma are not well
understood. Our multidisciplinary team has designed 3 well-integrated projects focusing on Interactions
between biologically critical hormonal pathways in uterine leiomyoma involving the transcription factors
progesterone receptor (PR) and FOXO, the signaling pathway PI3K/AKT and the pro-fibrotic factor TGF-beta.
Project I (Bulun) will be pursued to understand the mechanisms as to how antl-progestins such as RU486
reduce tumor size. We hypothesize that progesterone regulates a number of critical genes, that favors
increased proliferation and decreased apoptosis of leiomyoma smooth muscle cells, whereas anti-progestins
reverse this effect by enhancing apoptosis and decreasing proliferation. Project II (Kim/Chakravarti) will
determine the role of the PI3K/AKT/F0X0 signaling pathway regulating leiomyoma cell growth and survival in
response to progesterone. We hypothesize that progesterone Induces proliferation of leiomyoma cells
through activation of the PI3K/AKT/F0X0 signaling pathway and that Inhibitors of the AKT pathway should
override the proliferative effects of progesterone and promote apoptosis. Project III (Nowak) will define the
mechanisms as to how antifibrotic drugs regulate leiomyoma growth. We hypothesize that the Increased
proliferation exhibited by leiomyoma smooth muscle cells Is due to a major shift in the extracellular matrix
environment caused by increased synthesis of new, monomeric collagen type I by these cells. We will
determine whether antifibrotic drugs may be an effective new treatment for leiomyomas. These projects are
supported by an Administrative Core (Bulun) and Tissue Procurement and Cell Culture Core (Kurita).
Overall, as part of our long range goal, all projects investigate local hormonal signaling regulating apoptosis
and proliferation as biologic endpoints and test existing and upcoming pharmaceutical compounds that target
these pathways in uterine leiomyomata.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Estrogen, Astrocyte Reactivity, and Sex Differences in Alzheimer's Disease
-
批准号:10662993
-
项目类别:
-
资助金额:$194.24万
-
财政年份:2023
-
负责人:Serdar E. Bulun
-
依托单位:
Environmental Pollutants and AHR pathway in Uterine Leiomyoma
-
批准号:10567192
-
项目类别:
-
资助金额:$63.22万
-
财政年份:2022
-
负责人:Serdar E. Bulun
-
依托单位:
Gut Microbiome and Steroid Hormones
-
批准号:10054472
-
项目类别:
-
资助金额:$20.45万
-
财政年份:2020
-
负责人:Serdar E. Bulun
-
依托单位:
Epigenome, MED12 and Progesterone Action in Uterine Leiomyomas
-
批准号:10396486
-
项目类别:
-
资助金额:$48.87万
-
财政年份:2019
-
负责人:Serdar E. Bulun
-
依托单位:
Estrogen and Abdominal Muscle Fibrosis
-
批准号:10546452
-
项目类别:
-
资助金额:$59.54万
-
财政年份:2019
-
负责人:Serdar E. Bulun
-
依托单位:
Admin Core
-
批准号:10613374
-
项目类别:
-
资助金额:$10.09万
-
财政年份:2019
-
负责人:Serdar E. Bulun
-
依托单位:
Admin Core
-
批准号:10396485
-
项目类别:
-
资助金额:$10.09万
-
财政年份:2019
-
负责人:Serdar E. Bulun
-
依托单位:
Northwestern Uterine Leiomyoma Research Center
-
批准号:10153840
-
项目类别:
-
资助金额:$146.67万
-
财政年份:2019
-
负责人:Serdar E. Bulun
-
依托单位:
Estrogen and Abdominal Muscle Fibrosis
-
批准号:9916751
-
项目类别:
-
资助金额:$60.03万
-
财政年份:2019
-
负责人:Serdar E. Bulun
-
依托单位:
Estrogen and Abdominal Muscle Fibrosis
-
批准号:10117246
-
项目类别:
-
资助金额:$59.54万
-
财政年份:2019
-
负责人:Serdar E. Bulun
-
依托单位:
Epigenome, MED12 and Progesterone Action in Uterine Leiomyomas
-
批准号:10153842
-
项目类别:
-
资助金额:$48.87万
-
财政年份:2019
-
负责人:Serdar E. Bulun
-
依托单位:
Estrogen and Abdominal Muscle Fibrosis
-
批准号:9763879
-
项目类别:
-
资助金额:$60.5万
-
财政年份:2019
-
负责人:Serdar E. Bulun
-
依托单位:
Estrogen and Abdominal Muscle Fibrosis
-
批准号:10341215
-
项目类别:
-
资助金额:$59.54万
-
财政年份:2019
-
负责人:Serdar E. Bulun
-
依托单位:
Northwestern Uterine Leiomyoma Research Center
-
批准号:10005417
-
项目类别:
-
资助金额:$146.62万
-
财政年份:2019
-
负责人:Serdar E. Bulun
-
依托单位:
Epigenome, MED12 and Progesterone Action in Uterine Leiomyomas
-
批准号:10613376
-
项目类别:
-
资助金额:$48.87万
-
财政年份:2019
-
负责人:Serdar E. Bulun
-
依托单位:
Admin Core
-
批准号:10153841
-
项目类别:
-
资助金额:$10.09万
-
财政年份:2019
-
负责人:Serdar E. Bulun
-
依托单位:
Northwestern Uterine Leiomyoma Research Center
-
批准号:10613373
-
项目类别:
-
资助金额:$146.67万
-
财政年份:2019
-
负责人:Serdar E. Bulun
-
依托单位:
Endometriosis and Retinoids
-
批准号:9376221
-
项目类别:
-
资助金额:$6.83万
-
财政年份:2015
-
负责人:Serdar E. Bulun
-
依托单位:
Endometriosis and Retinoids
-
批准号:9126988
-
项目类别:
-
资助金额:$47.34万
-
财政年份:2015
-
负责人:Serdar E. Bulun
-
依托单位:
Core A: Administrative Core
-
批准号:8308002
-
项目类别:
-
资助金额:$4.93万
-
财政年份:2011
-
负责人:Serdar E. Bulun
-
依托单位:
国内基金
海外基金
基于构建骨骼类器官模型探究Fanconi anemia信号通路调控电刺激诱导神经化成骨过程的机制研究
-
批准号:82302715
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:熊泽康
-
依托单位:
FANCM蛋白在传统Fanconi anemia通路以外对保护基因组稳定性的功能
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2021
-
负责人:陈英伟
-
依托单位:
范可尼贫血(Fanconi Anemia)基因FANCM在复制后修复中的作用及FA癌症抑制通路的机制研究
-
批准号:31200592
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2012
-
负责人:孙伟力
-
依托单位: